Explore All Access
Check if your research matches the topics covered in Expert Opinion on Drug Safety?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Expert Opinion on Drug Safety : Impact Factor & More
eISSN: 1744-764XpISSN: 1474-0338
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Expert Opinion on Drug Safety is a monthly peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre (University of Toronto). Less
Expert Opinion on Drug Safety Key Metrics
CiteScore 
6.1
Eigenfactor
0.005 - 0.01
H-Index
81
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.17
Time to Accept
4
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months17%
4 to 6 months54%
7 to 9 months26%
Above 9 months3%
Did you find this useful?
Topics Covered on Expert Opinion on Drug Safety
Cancer
Multiple sclerosis
Somatostatin
Amyloidosis
Hypophosphatemia
Botulinum toxin
Ulcerative colitis
Fixed-dose combination
Immune checkpoint
Type 2 diabetes
Migraine
Breast cancer
Adjuvant therapy
Rheumatoid arthritis
Toxicity
Psoriasis
Drug treatment
Paroxysmal nocturnal hemoglobinuria
Neuroendocrine tumors
Breastfeeding
Expert Opinion on Drug Safety Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Opinion on Drug Safety
Safety assessment of cabozantinib in patients with renal cell carcinoma: retrospective pharmacovigilance study based on FAERS database
- 3 Apr 2025
- Expert Opinion on Drug Safety
Adverse events associated with aromatase inhibitors: An Analysis of Real-World Datasets and drug-gene interaction network
- 4 Mar 2025
- Expert Opinion on Drug Safety
Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database
- 4 Mar 2025
- Expert Opinion on Drug Safety
Statin alternatives for the treatment of hypercholesterolemia - a safety evaluation
- 2 Jan 2025
- Expert Opinion on Drug Safety
Is metformin safe in pregnancy: a focus on offspring outcomes
- 2 Jan 2025
- Expert Opinion on Drug Safety
Adverse event profiles of drug-induced decreased libido: an assessment of the US food and drug administration adverse event reporting system
- 1 Dec 2024
- Expert Opinion on Drug Safety
Safety assessment of cabozantinib in patients with renal cell carcinoma: retrospective pharmacovigilance study based on FAERS database
- 3 Apr 2025
- Expert Opinion on Drug Safety
Adverse events associated with aromatase inhibitors: An Analysis of Real-World Datasets and drug-gene interaction network
- 4 Mar 2025
- Expert Opinion on Drug Safety
Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database
- 4 Mar 2025
- Expert Opinion on Drug Safety
Statin alternatives for the treatment of hypercholesterolemia - a safety evaluation
- 2 Jan 2025
- Expert Opinion on Drug Safety
Is metformin safe in pregnancy: a focus on offspring outcomes
- 2 Jan 2025
- Expert Opinion on Drug Safety
Adverse event profiles of drug-induced decreased libido: an assessment of the US food and drug administration adverse event reporting system
- 1 Dec 2024
- Expert Opinion on Drug Safety
Compare Similar Journals with Expert Opinion on Drug Safety
Select Journals to Compare with Expert Opinion on Drug Safety
Total journals - 9
You can select up to 3 Journals at a time
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Medicine
Publisher: Elsevier
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Clinical Medicine
Publisher: MDPI
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Scientific Reports
Publisher: NATURE PORTFOLIO
Drug Safety
Publisher: ADIS INT LTD
Advances in Therapy
Publisher: SPRINGER
0 Journals Selected to compare with
Expert Opinion on Drug Safety
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Expert Opinion on Drug Safety
How long has Expert Opinion on Drug Safety been actively publishing? 
Expert Opinion on Drug Safety has been in operation since 2002 till date.
What is the publishing frequency of Expert Opinion on Drug Safety?
Expert Opinion on Drug Safety published with a Bi-monthly frequency.
How many articles did Expert Opinion on Drug Safety publish last year?
In 2023, Expert Opinion on Drug Safety publsihed 179 articles.
What is the eISSN & pISSN for Expert Opinion on Drug Safety?
For Expert Opinion on Drug Safety, eISSN is 1744-764X and pISSN is 1474-0338.
What is Citescore for Expert Opinion on Drug Safety?
Citescore for Expert Opinion on Drug Safety is 6.1.
What is the H Index for Expert Opinion on Drug Safety ?
H Index for Expert Opinion on Drug Safety is 81.
What is SNIP score for Expert Opinion on Drug Safety?
SNIP score for Expert Opinion on Drug Safety is 1.17.
What is the SJR for Expert Opinion on Drug Safety?
SJR for Expert Opinion on Drug Safety is Q2.
Who is the publisher of Expert Opinion on Drug Safety?
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Drug Safety.
